Cargando…

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome

The interleukin-1 (IL-1) family of cytokines has been implicated in the pathogenesis of atherosclerosis in previous studies. The NLRP3 inflammasome has recently emerged as a pivotal regulator of IL-1β maturation and secretion by macrophages. Little is currently known about a possible role for the NL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menu, P, Pellegrin, M, Aubert, J-F, Bouzourene, K, Tardivel, A, Mazzolai, L, Tschopp, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101814/ https://www.ncbi.nlm.nih.gov/pubmed/21451572 http://dx.doi.org/10.1038/cddis.2011.18

Ejemplares similares

ER stress activates the NLRP3 inflammasome via an UPR-independent pathway
por: Menu, P, et al.
Publicado: (2012)

Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects
por: Pellegrin, Maxime, et al.
Publicado: (2015)

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
por: Wang, Renqing, et al.
Publicado: (2017)

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice
por: Zhao, Jingfei, et al.
Publicado: (2020)

Exercise Prior to Lower Extremity Peripheral Artery Disease Improves Endurance Capacity and Hindlimb Blood Flow by Inhibiting Muscle Inflammation
por: Pellegrin, Maxime, et al.
Publicado: (2021)

Whole-Grain Highland Barley Attenuates Atherosclerosis Associated with NLRP3 Inflammasome Pathway and Gut Microbiota in ApoE(−/−) Mice
por: Wu, Tong, et al.
Publicado: (2023)

Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice
por: Lou, Xiaoqian, et al.
Publicado: (2021)

HHcy Induces Pyroptosis and Atherosclerosis via the Lipid Raft-Mediated NOX-ROS-NLRP3 Inflammasome Pathway in apoE(−/−) Mice
por: Liu, Sijun, et al.
Publicado: (2022)

Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability
por: Pellegrin, Maxime, et al.
Publicado: (2018)

β-hydroxybutyrate Impedes the Progression of Alzheimer’s Disease and Atherosclerosis in ApoE-Deficient Mice
por: Krishnan, Manigandan, et al.
Publicado: (2020)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Physical Performance and Skeletal Muscle Transcriptional Adaptations Are Not Impacted by Exercise Training Frequency in Mice with Lower Extremity Peripheral Artery Disease
por: Lavier, Jessica, et al.
Publicado: (2023)

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE(−/−) Mice
por: Liu, Huadong, et al.
Publicado: (2019)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T‐cell polarization during early and late stages
por: Pellegrin, Maxime, et al.
Publicado: (2014)

The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient Mice
por: Mörk, Lisa-Mari, et al.
Publicado: (2013)

Dickkopf‐3 Ablation Attenuates the Development of Atherosclerosis in ApoE‐Deficient Mice
por: Cheng, Wen‐Lin, et al.
Publicado: (2017)

Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice
por: Kader, Tanjina, et al.
Publicado: (2020)

SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice
por: Guan, Hua, et al.
Publicado: (2023)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Prevention of Atherosclerosis Progression by 9-cis-β-Carotene Rich Alga Dunaliella in apoE-Deficient Mice
por: Harari, Ayelet, et al.
Publicado: (2013)

Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
por: Ma, Sai, et al.
Publicado: (2018)

Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis
por: Yuan, Ruosen, et al.
Publicado: (2022)

Impact of aerobic exercise type on blood flow, muscle energy metabolism, and mitochondrial biogenesis in experimental lower extremity artery disease
por: Pellegrin, Maxime, et al.
Publicado: (2020)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Bisphenol A Increases Atherosclerosis in Pregnane X Receptor‐Humanized ApoE Deficient Mice
por: Sui, Yipeng, et al.
Publicado: (2014)

Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice
por: Wang, Lei, et al.
Publicado: (2023)

Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in apoE-deficient mice
por: Sang, Hui, et al.
Publicado: (2012)

Effects of Icariin on Atherosclerosis and Predicted Function Regulatory Network in ApoE Deficient Mice
por: Zhang, Yibing, et al.
Publicado: (2018)

Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells
por: Delgado-Maroto, Virginia, et al.
Publicado: (2017)

Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE(−/−) mice
por: Imai, Takashi, et al.
Publicado: (2022)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

T Cell-Specific Overexpression of TGFß1 Fails to Influence Atherosclerosis in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2013)

Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal
por: Dostert, Catherine, et al.
Publicado: (2009)

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
por: Cloux, Anne-Julie, et al.
Publicado: (2019)

Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4
por: McNeela, Edel A., et al.
Publicado: (2010)

NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes
por: Gustin, Audrey, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u2sm7f43nn1nunkopsvg4d70f7